News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|July 22, 2016

Improving Outcomes in Diabetic Macular Edema: The Impact of New Therapies in Managed Care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

soft tissue sarcoma image | Image credit: Dr_Microbe - stock.adobe.com

Sarcoma Gene Signature May Predict Who Benefits From Pazopanib

ByLaura Joszt, MA

August 16th 2026

Man's eye | Image credit: booleen - stock.adobe.com

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

August 14th 2026

GLP-1s - Image Credit: ©K KStock - stock.adobe.com.jpeg

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

August 14th 2026

Rising columns of coins with an overlaid bar chart | Image credit: THAWEERAT - stock.adobe.com

ICER Draft Flags High Cost of New Hypertension Drug Class

ByLaura Joszt, MA

August 14th 2026

HemeResearcher | Image Credit: © Sharne Tpeopleimages.com-stock.adobe.com

MDS/MPN Response Criteria Tied to Survival

ByMaggie L. Shaw

August 14th 2026

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

Sarcoma Gene Signature May Predict Who Benefits From Pazopanib

Lifestyle Factors Offer Actionable Targets in MASLD Management: Zobair M. Younossi, MD